This document is an application form for a 2011 research project proposal. The applicant proposes researching how to amplify the effectiveness of cyclopyrrolone drugs like zopiclone and other chiral molecules through chiral switching and recombinant drug technology. Specifically, the applicant proposes using chiral switching to produce single enantiomers to reduce side effects and increase dose effectiveness. The applicant also proposes using recombinant processes to produce a "universal enantiomer" that could prolong the effect of most drugs when combined with them, potentially providing a fundamental shift in how the human immune system deals with disease. The form requests contact information for two referees who can authorize the applicant to act as the contact for matters relating to the application.